BACKGROUND Chemotherapy‐induced cognitive dysfunction in patients with breast
carcinoma has been described previously. However, those studies only assessed patients' …

BACKGROUND Retrospective trials have reported that chemotherapy‐induced cognitive
dysfunction was experienced by a subset of patients with breast carcinoma. However, recent …

Objectives: Recent studies suggest that standard dose chemotherapy for breast cancer may
cross the blood–brain barrier. However, the evidence for chemotherapy‐induced cognitive …

Purpose Published cross-sectional studies have revealed that chemotherapy for breast
cancer is associated with significant cognitive impairments. However, because these studies …

This article provides an overview of the most recent literature on the cognitive adverse
effects of chemotherapy in patients with breast cancer. The prevalence of cognitive …

Self-perceived problems of cognitive functioning after treatment for early-stage breast cancer
have the potential to substantially affect the lives of patients. In the past two decades …

The goal of adjuvant chemotherapy in the treatment of breast cancer is to reduce recurrence
and mortality. With respect to quality of life and morbidity, however, such treatments come at …

A subset of breast cancer survivors are reporting cognitive impairment after cancer
treatment, which has commonly been attributed to the receipt of chemotherapy and …

Cognitive side effects of systemic chemotherapy have become an increasing concern
among breast cancer survivors, their families, and health care professionals. A growing body …

BACKGROUND Evidence suggests that women diagnosed with early‐stage breast
carcinoma may experience cognitive problems as a consequence of adjuvant chemotherapy …